6/21/2022 8:10:03 AM
Cortexyme Says Preclinical Data Demonstrate Efficacy Of COR803 For
Treatment Of Coronavirus Infections
6/13/2022 8:17:14 AM
Cortexyme Appoints June Bray To Board
5/20/2022 8:04:43 AM
Cortexyme Appoints Philip Low To Board
5/20/2022 8:02:49 AM
Cortexyme Completes Acquisition Of Novosteo
3/21/2022 8:07:48 AM
Cortexyme : Data Shows Potential Benefit Of Lysine Gingipain Inhibition In Mild To Moderate Alzheimer's Population
3/8/2021 8:51:05 AM
Cortexyme Announces Partnership With Parkinson Study Group
2/15/2021 9:30:06 PM
Cortexyme Says FDA Places Partial Clinical Hold On Atuzaginstat In
Alzheimer's Disease